About Prof. Zou Qiang
Prof. Zou Qiang (邹强) is a Chief Physician (主任医师), Professor, Doctoral Supervisor, and the academic leader of the Department of Thyroid and Breast Surgery at Huashan Hospital, Fudan University. As the discipline leader of one of Shanghai's most respected thyroid and breast surgery programs, Prof. Zou brings comprehensive expertise in the early diagnosis, surgical management, and precision treatment of thyroid and breast tumors, with a particular focus on minimally invasive and endoscopic approaches that minimize surgical trauma and optimize cosmetic outcomes.
Huashan Hospital — one of China's most prestigious academic medical centers and the country's foremost neurology and neurosurgery institution — provides Prof. Zou with a strong multidisciplinary platform for complex thyroid and breast cases, including access to advanced imaging, pathology, endocrinology, and oncology expertise within a single institution.
Clinical Expertise
- Thyroid tumor surgery — early diagnosis and surgical management of thyroid cancer (papillary, follicular, medullary) and benign thyroid tumors; total thyroidectomy, hemithyroidectomy, and neck dissection with precision oncological technique
- Endoscopic minimally invasive thyroid surgery — laparoscopic and endoscopic thyroid surgery via remote access approaches (transoral, transaxillary, transbreast) for eligible patients seeking scarless outcomes
- Breast tumor early diagnosis and minimally invasive treatment — ultrasound-guided vacuum-assisted biopsy (VAB) and minimally invasive excision of breast nodules; early-stage breast cancer diagnosis and surgical planning
- Breast cancer surgery — breast-conserving surgery, mastectomy, sentinel lymph node biopsy, and axillary dissection; oncoplastic techniques for optimal functional and cosmetic outcomes
- Breast reconstruction — immediate and delayed reconstruction including implant-based and autologous tissue options, in coordination with plastic surgery
- Breast reshaping and reconstruction surgery — oncoplastic breast surgery combining cancer resection with aesthetic reshaping; breast reconstruction after mastectomy
- General surgery — management of general surgical conditions within the broader clinical framework
Why Prof. Zou Qiang?
As the academic discipline leader of Huashan Hospital's Thyroid and Breast Surgery Department, Prof. Zou occupies a position of institutional authority that reflects both his clinical expertise and his role in shaping the department's standards and direction. His doctoral supervisor status at Fudan University signals a sustained commitment to research and education that keeps his clinical practice at the frontier of evidence-based medicine.
His combined expertise in thyroid and breast surgery — with a particular emphasis on minimally invasive and endoscopic techniques — makes him a comprehensive resource for patients with concerns in both areas, which is not uncommon given the overlapping demographic of women affected by thyroid and breast conditions. For patients who prioritize cosmetic outcomes alongside oncological safety, Prof. Zou's experience in endoscopic thyroid surgery and oncoplastic breast surgery provides a meaningful advantage over surgeons who focus exclusively on conventional open approaches.
Huashan Hospital's institutional strength in neurology and neurosurgery also provides a unique advantage for thyroid cancer patients with CNS involvement or complex neurological considerations — a level of integrated expertise that is not available at most thyroid surgery centers.
Hospital: Huashan Hospital, Fudan University
Huashan Hospital is one of China's most prestigious academic medical centers, affiliated with Fudan University School of Medicine and consistently ranked among the top hospitals in the country. It is internationally recognized as China's foremost neurology and neurosurgery center, and its Department of Thyroid and Breast Surgery benefits from this strong multidisciplinary environment. The hospital operates across multiple campuses including the main campus and the Jiangsu Road branch, providing convenient access for patients across Shanghai. Its advanced imaging, pathology, and endocrinology departments provide close collaboration for the comprehensive management of thyroid and breast conditions.
About Thyroid & Breast Cancer
Thyroid and breast cancers are among the most common malignancies affecting women globally, and both are increasingly diagnosed at early stages due to improved screening. Key facts for international patients:
- Thyroid cancer incidence is rising globally at ~3% per year; papillary thyroid carcinoma has an excellent prognosis with appropriate surgery; early diagnosis through ultrasound screening is increasingly common in Asia
- Minimally invasive thyroid surgery: transoral and transaxillary endoscopic approaches achieve equivalent oncological outcomes to open surgery at high-volume centers, with no visible neck scar
- Breast cancer screening: mammography and ultrasound are complementary; MRI is recommended for high-risk patients (BRCA1/2 mutation carriers, strong family history)
- Breast-conserving surgery: equivalent survival to mastectomy for eligible early-stage breast cancer; requires post-operative radiation therapy
- Oncoplastic breast surgery: combines cancer resection with immediate breast reshaping to optimize cosmetic outcomes; reduces the psychological impact of breast cancer surgery
- Breast reconstruction: immediate reconstruction at the time of mastectomy is associated with better psychological outcomes; options include tissue expander/implant, DIEP flap, and latissimus dorsi flap
What to Prepare Before Your Consultation
To enable Prof. Zou's team to conduct a thorough remote case review, international patients should prepare:
For thyroid concerns:
- Neck ultrasound report with TI-RADS scoring and measurements of all nodules and lymph nodes
- FNA cytology report (Bethesda classification) if biopsy has been performed
- Thyroid function tests: TSH, free T4, free T3
- CT scan of the neck and chest with contrast if locally advanced disease is suspected
- Tumor markers: thyroglobulin (Tg), anti-Tg antibodies; calcitonin and CEA for medullary thyroid cancer
For breast concerns:
- Mammogram and breast ultrasound reports with BI-RADS scoring
- Breast MRI if available (recommended for high-risk patients or pre-surgical planning)
- Core biopsy or FNA pathology report if biopsy has been performed
- Hormone receptor status (ER, PR, HER2) and Ki-67 if breast cancer is confirmed
- BRCA1/2 genetic testing results if available
How CMCS Can Help
China Medical Concierge Shanghai (CMCS) coordinates access to Prof. Zou Qiang and the Huashan Hospital Thyroid and Breast Surgery team for international patients. Our services include:
- Remote case review and pre-consultation assessment before you travel
- Priority appointment scheduling with Prof. Zou's team at Huashan Hospital (main campus or Jiangsu Road branch — please confirm current schedule via official channels)
- Full translation of ultrasound reports, pathology, and treatment plans
- In-hospital accompaniment by a dedicated English-speaking case manager
- Accommodation, airport transfer, and logistics coordination in Shanghai
- Post-discharge follow-up and remote consultation support after returning home
Contact us to begin your case review:
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
0 Kommentare